Odey Asset Management Group’s Pfizer PFE Stock Holding History

Odey Asset Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,000	Closed	-$1.54M	–	29
2022 Q4	$1.54M	Buy	+30,000	New	+$1.44M	0.46%	21
2022 Q2	–	Sell	-55,000	Closed	-$2.85M	–	32
2022 Q1	$2.85M	Sell	55,000 -75,000	-58%	-$3.89M	0.86%	23
2021 Q4	$7.68M	Buy	130,000 +60,000	+86%	+$2.97M	2.27%	10
2021 Q3	$3.01M	Buy	+70,000	New	+$3.1M	0.8%	31
2016 Q3	–	Sell	-217,229	Closed	-$7.26M	–	91
2016 Q2	$7.26M	Buy	217,229 +132,909	+158%	+$4.24M	0.65%	26
2016 Q1	$2.37M	Buy	+84,320	New	+$2.41M	0.26%	50
2014 Q4	–	Sell	-29,512	Closed	-$828K	–	88
2014 Q3	$828K	Buy	+29,512	New	+$828K	0.03%	71

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Odey Asset Management Group's PFE Position: Q1 2023 in Review

Odey Asset Management Group sold out of Pfizer (PFE) in Q1 2023, closing a stake of 30,000 shares — an estimated $1.54M sold.

Odey Asset Management Group first reported a position in PFE in Q3 2014 and held it in 7 quarters. The position peaked at $7.68M in Q4 2021. 3,105 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Odey Asset Management Group reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Odey Asset Management Group sold 30,000 Pfizer shares in Q1 2023, an estimated $1.54M.
Odey Asset Management Group first reported a position in Pfizer in Q3 2014 and held it in 7 quarters.
Odey Asset Management Group's Pfizer position peaked at $7.68M in Q4 2021.
3,105 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Odey Asset Management Group's 13F filing for Q1 2023, filed 15 May 2023.